Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Cash Flow Quality Index
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow Quality Index of 3.80x as of September 2025. Operating cash flow of CN¥22.69 Million exceeds net income of CN¥5.98 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Henan Taloph Pharmaceutical Stock Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Henan Taloph Pharmaceutical Stock Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Henan Taloph Pharmaceutical Stock Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Henan Taloph Pharmaceutical Stock Co Ltd. For live market cap and the full company financial profile, see Henan Taloph Pharmaceutical Stock Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | CN¥47.16 Million | CN¥60.00 Million | ▲ +206.2% |
| 2024 | -0.74x | CN¥-39.59 Million | CN¥53.49 Million | ▼ -173.7% |
| 2023 | 1.00x | CN¥43.74 Million | CN¥43.56 Million | ▼ -93.2% |
| 2021 | 14.70x | CN¥99.66 Million | CN¥6.78 Million | ▲ +452.5% |
| 2020 | 2.66x | CN¥73.43 Million | CN¥27.60 Million | ▲ +172.8% |
| 2019 | 0.98x | CN¥41.53 Million | CN¥42.57 Million | ▼ -69.0% |
| 2017 | 3.14x | CN¥23.17 Million | CN¥7.37 Million | ▼ -91.7% |
| 2016 | 38.10x | CN¥70.60 Million | CN¥1.85 Million | ▲ +240.7% |
| 2015 | 11.18x | CN¥49.27 Million | CN¥4.41 Million | ▲ +526.6% |
| 2014 | 1.78x | CN¥89.54 Million | CN¥50.17 Million | ▲ +1488.0% |
| 2013 | -0.13x | CN¥-6.65 Million | CN¥51.70 Million | ▼ -104.7% |
| 2012 | 2.73x | CN¥87.45 Million | CN¥32.04 Million | ▲ +54094.8% |
| 2011 | 0.01x | CN¥105.20K | CN¥20.89 Million | ▲ +100.7% |
| 2010 | -0.72x | CN¥-20.00 Million | CN¥27.82 Million | ▼ -205.8% |
| 2009 | 0.68x | CN¥21.45 Million | CN¥31.56 Million | ▼ -9.7% |
| 2008 | 0.75x | CN¥18.13 Million | CN¥24.09 Million | ▼ -24.8% |
| 2007 | 1.00x | CN¥21.34 Million | CN¥21.31 Million | ▲ +990.3% |
| 2006 | 0.09x | CN¥1.59 Million | CN¥17.36 Million | ▲ +459.3% |
| 2005 | 0.02x | CN¥276.30K | CN¥16.83 Million | ▼ -98.6% |
| 2004 | 1.15x | CN¥18.25 Million | CN¥15.94 Million | ▲ +613.9% |
| 2003 | 0.16x | CN¥3.74 Million | CN¥23.31 Million | ▼ -76.8% |
| 2002 | 0.69x | CN¥7.47 Million | CN¥10.78 Million | ▼ -63.5% |
| 2001 | 1.90x | CN¥55.03 Million | CN¥29.00 Million | ▲ +9194.3% |
| 2000 | 0.02x | CN¥875.36K | CN¥42.87 Million | ▼ -99.2% |
| 1999 | 2.58x | CN¥99.32 Million | CN¥38.44 Million | ▼ -4.6% |
| 1998 | 2.71x | CN¥28.04 Million | CN¥10.35 Million | — |